04 June 2024
: Case report 
Rare Pathogens in Peritoneal Dialysis-Associated Peritonitis: A Comprehensive Case Study and Guideline Review
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease, Adverse events of drug therapy
Abbas Mohammadi1ABCDEF*, Hossein Akhondi1ADE, Dhiresh R. Joshi2DE, Seyed Abbas Mirabbasi1DEDOI: 10.12659/AJCR.943953
Am J Case Rep 2024; 25:e943953
Figure 1. The figure depicts the temporal progression of cell count from peritoneal fluid analysis and the corresponding antibiotic regimen during 2 distinct hospitalizations for this patient, with intravenous administration denoted unless specified as “IP,” indicating intraperitoneal delivery. Cefe – cefepime; Metro – metronidazole; Merrem – meropenem; Vanco – vancomycin; Erava – eravacycline, Ert – ertapenem; IP – intraperitoneal; DC – discharge, PD – peritoneal dialysis.